Meeting | Virtual
Event Title
Drug Supply Chain Security Act pilot project program and enhanced drug distribution security
December 8 - 9, 2020
- Date:
- December 8 - 9, 2020
- Day1:
- Tue, Dec 8
- Day2:
- Wed, Dec 9
FDA hosted a virtual public meeting to provide members of the pharmaceutical distribution supply chain and other stakeholders an opportunity to provide input on strategies and issues related to enhanced drug distribution security and discuss results from FDA’s DSCSA pilot project program.
The public meeting focused on:
- Findings and lessons learned from the pilot project program
- Other piloting or piloted activities related to DSCSA implementation
- System attributes necessary to enable secure product tracing, including:
- Interoperability among trading partners, FDA and other federal or state official(s)
- Enhanced product tracing activities involving the exchange of data in a secure manner, including management and maintenance of the data
- The use of aggregation and inference for product tracing and/or verification
- Enhanced verification activities involving communication among trading partners and FDA, and exchanging data in a secure manner
Related information
- Federal Register notice reopening of comment period until 6/22/2021
- Federal Register meeting notice
- Drug Supply Chain Security Act (DSCSA)
Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.
Event Materials
Title | File Type/Size |
---|---|
Agenda_DSCSA_PublicMeeting_pdf | pdf (136.68 KB) |
ConceptsAndTerminology_pdf | pdf (45.40 KB) |
DiscussionTopics_pdf | pdf (28.63 KB) |
DSCSA Public Meeting Slides 12.8.20 | pdf (523.81 KB) |
December 9 AdobeCC Transcript | pdf (84.46 KB) |
Panel 1 DSCSA Public Meeting December 8 | pdf (4.27 MB) |
Panel 2 DSCSA Public Meeting December 8 | pdf (3.42 MB) |
Panel 3 DSCSA Public Meeting December 8 | pdf (4.53 MB) |
Panel 4 External Pilots_DSCSA Public Meeting December 8 | pdf (1.88 MB) |